| RS886042402 |
COL6A3
|
Health Risk |
Pathogenic |
— |
| RS886042405 |
GALT
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS886042409 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886042410 |
TRIM32
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, TRIM32-related disorder |
| RS886042414 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS886042415 |
DNAJB6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6), Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) |
| RS886042417 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS886042418 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS886042421 |
SYNE1
|
Health Risk |
Pathogenic |
SYNE1-related disorder, Autosomal recessive ataxia |
| RS886042428 |
ROR2
|
Health Risk |
Pathogenic |
— |
| RS886042430 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS886042437 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS886042439 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS886042440 |
CAPN3
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy |
| RS886042441 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS886042442 |
ANO5
|
Health Risk |
Pathogenic |
— |
| RS886042445 |
CRPPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS886042447 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886042449 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886042452 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886042457 |
NEK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Short-rib thoracic dysplasia 6 with or without polydactyly, Amyotrophic lateral sclerosis |
| RS886042458 |
SHH
|
Health Risk |
Pathogenic/Likely pathogenic |
Holoprosencephaly 3, Holoprosencephaly 3 |
| RS886042459 |
POMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS886042462 |
GDF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Type A2 brachydactyly, Type A2 brachydactyly |
| RS886042463 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS886042465 |
NRXN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pitt-Hopkins-like syndrome 2, Pitt-Hopkins-like syndrome 2 |
| RS886042467 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Joubert syndrome |
| RS886042468 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
NSD1-related disorder, NSD1-related disorder |
| RS886042469 |
ST3GAL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS886042473 |
COL1A1
|
Health Risk |
Pathogenic |
— |
| RS886042477 |
PLG
|
Health Risk |
Pathogenic |
— |
| RS886042478 |
CAPN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS886042481 |
SYN1
|
Health Risk |
Pathogenic |
— |
| RS886042484 |
EXT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS886042490 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886042495 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886042499 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886042502 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886042503 |
SGCB
|
Health Risk |
Pathogenic/Likely pathogenic |
Qualitative or quantitative defects of beta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS886042504 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS886042506 |
FKRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2I, Walker-Warburg congenital muscular dystrophy |
| RS886042507 |
TRPS1
|
Health Risk |
Pathogenic |
— |
| RS886042511 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886042513 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Walker-Warburg congenital muscular dystrophy, Cardiovascular phenotype |
| RS886042517 |
NPHS1
|
Health Risk |
Pathogenic |
— |
| RS886042519 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Wilson disease |
| RS886042525 |
FOXE3
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital primary aphakia, Anterior segment dysgenesis |
| RS886042527 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS886042528 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, SCN1A-related disorder |
| RS886042532 |
ASXL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS886042533 |
CLN6
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS886042535 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886042539 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886042540 |
SGCG
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS886042541 |
COL6A2
|
Health Risk |
Likely pathogenic |
— |
| RS886042543 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886042546 |
SGCB
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS886042553 |
COL10A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886042554 |
CRPPA
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS886042556 |
ANO5
|
Health Risk |
Likely pathogenic |
— |
| RS886042557 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS886042562 |
ABCB4
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive familial intrahepatic cholestasis type 3, Inborn genetic diseases |
| RS886042568 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS886042572 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS886042573 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS886042578 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy |
| RS886042581 |
DYSF
|
Health Risk |
Pathogenic |
— |
| RS886042584 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Miyoshi muscular dystrophy 1 |
| RS886042588 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy, limb-girdle |
| RS886042590 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS886042600 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS886042602 |
COL1A1
|
Health Risk |
Pathogenic |
— |
| RS886042603 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS886042604 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Abnormality of the musculature |
| RS886042605 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS886042609 |
COL1A1
|
Health Risk |
Pathogenic |
— |
| RS886042610 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young type 2 |
| RS886042612 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS886042613 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS886042614 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS886042616 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS886042617 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS886042618 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dystrophin, Duchenne muscular dystrophy |
| RS886042619 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS886042621 |
CCDC40
|
Health Risk |
Pathogenic |
— |
| RS886042622 |
PAX6
|
Health Risk |
Pathogenic |
Irido-corneo-trabecular dysgenesis, Aniridia 1 |
| RS886042623 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886042624 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
ANO5-Related Muscle Diseases, Gnathodiaphyseal dysplasia |
| RS886042626 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS886042632 |
DYSF
|
Health Risk |
Pathogenic |
— |
| RS886042633 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Distal myopathy with anterior tibial onset, Miyoshi muscular dystrophy 1 |
| RS886042635 |
DYSF
|
Health Risk |
Pathogenic |
Miyoshi muscular dystrophy 1, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886042636 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS886042637 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS886042641 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS886042643 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886042645 |
GALC
|
Health Risk |
Likely pathogenic |
— |
| RS886042646 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886042647 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS886042651 |
COL2A1
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia congenita, COL2A1-related disorder |